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GENERAL INFORMATION 
 
Unless otherwise noted, all materials were used as received from commercial sources without 
further purification. All aldehydes, amines, and diarylmethanols were purchased from Aldrich, 
Alfa Aesar, Acros, and Combi-Blocks. Bromodiphenylmethane, cesium carbonate, dry sodium 
hydride, and sodium tert-butoxide were purchased from Aldrich. All bulk solvents were 
purchased from VWR and used as received. Anhydrous DMSO was purchased from Aldrich. 1H 
and 13C spectra were recorded on a Varian Inova instrument (500 MHz and 125 MHz, 
respectively) or Bruker Ascend instrument with Prodigy broadband cryoprobe (400 MHz and 
100 MHz, respectively), and 19F NMR spectra were recorded on a Varian Mercury instrument 
(282 MHz). Spectra were internally referenced to SiMe4 or solvent signals. The following 
abbreviations (or combinations thereof) were used to explain multiplicities: s = singlet, d = 
doublet, t = triplet, q = quartet, sept = septet, m = multiplet, and b = broad. High-resolution mass 
spectra (HRMS) were provided by the California Institute of Technology Mass Spectrometry 
Facility using a JEOL JMS-600H High Resolution Mass Spectrometer. All HRMS were ionized 









Scheme S1: General depiction of two-step SNAr/5-exo-trig cyclization route for synthesizing 3-
amino-2,3-dihydro-2,2-diarylbenzofurans. 
 
General imine condensation procedure:1 To a 100-mL round-bottom flask equipped with a 
Teflon-coated magnetic stir bar, were added the appropriate amine (10.0 mmol), the appropriate 
ortho-fluorobenzaldehyde (10.0 mmol), and toluene (50 mL). The flask was equipped with a 
Dean–Stark apparatus wrapped in aluminum foil and a reflux condenser. The reaction was 
allowed to stir at vigorous reflux (140–150 °C) for 8 h. During the course of the reaction, water 
accumulated at the bottom of the Dean–Stark apparatus. The reaction mixture was allowed to 
cool to room temperature. A small aliquot was taken, concentrated in vacuo, and analyzed by 1H 
NMR to monitor reaction progress. (The ortho-fluorobenzaldehyde starting material possesses a 
characteristic 1H NMR peak at 10.2–10.5 ppm (s) in CDCl3, and the product possesses a 
characteristic 1H NMR peak at 8.3–8.6 ppm (s); comparison of these two peaks provides a 
convenient means of monitoring reaction progress.) In cases where the reaction had not 
proceeded to >95% conversion, an additional portion of amine commensurate with the amount 
remaining starting material was added, and the reaction was heated for an additional 2–4 h. Upon 
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removed in vacuo. The crude imine product was obtained as a colorless/yellow oil or off-white 
solid and was used in the subsequent step without further purification.  
 
General SNAr/5-exo-trig cyclization procedure:2 To a 100-mL Schlenk flask equipped with a 
Teflon-coated magnetic stir bar under Ar, were added dry NaH (252 mg, 10.5 mmol), DMSO (20 
mL), and the appropriate alcohol (10.5 mmol). Upon addition of the alcohol, vigorous bubbling 
was observed. The solution was allowed to stir at room temperature for 1 h, during which time 
the reaction mixture became homogenous. A solution of the crude ortho-fluorobenzaldehyde 
imine from the previous step (assumed to be 10.0 mmol) in DMSO (10 mL) was added. The 
reaction mixture was heated to 100 °C for 1 h, during which time it changed color from yellow to 
red to brown. After 1 h, a small aliquot of the reaction mixture was removed with a syringe and 
quenched with H2O. The resulting mixture was extracted with Et2O, and the organic phase was 
concentrated in vacuo and examined by 1H NMR spectroscopy to monitor reaction progress. 
(The starting material 1 has a characteristic 1H NMR peak at 8.3–8.6 ppm (s, 1H) in CDCl3, the 
intermediate 3 has a characteristic 1H NMR peak at 8.7–8.9 ppm (s, 1H), and the product has a 
characteristic 1H NMR peak at 4.8–5.9 (s or d, 1H); comparison of these three peaks provides a 
convenient means of monitoring reaction progress.) In instances where the reaction had not 
proceeded to completion (i.e., >95% conversion) an additional portion of NaH was added, and 
the reaction mixture was heated at 100 °C for an additional 1 h. Upon completion of the reaction, 
the flask was allowed to cool to room temperature. The reaction mixture was carefully poured 
into a separatory funnel containing 100 mL of H2O to quench residual base. The mixture was 
extracted with Et2O (3 × 100 mL). The combined organic layers were washed with water (100 
mL) and brine (100 mL), dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
product was obtained as a yellow/brown oil or solid and was purified by silica gel column 
chromatography.  
 




Scheme S2: Synthesis of 3a and subsequent base-mediated cyclization. 
 
2-(benzhydryloxy)benzaldehyde (5a): To a 250-mL round-bottom flask equipped 
with a Teflon-coated magnetic stir bar under Ar were added salicylaldehyde (S1) 
(1.07 mL, 10.0 mmol), bromodiphenylmethane (S2) (4.94 g, 20.0 mmol), potassium 
carbonate (2.76 g, 20.0 mmol), cesium carbonate (0.65 g, 2.00 mmol) and DMF (100 
mL). The reaction mixture was allowed to stir at 80 °C for 18 h. The flask was 
allowed to cool to room temperature, and the reaction was quenched with water and 
extracted with Et2O (3 × 100 mL). The combined organic layers were washed with water (50 
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product was obtained as a brown oil. Purification by silica gel column chromatography using 
10:1 hexane:Et2O as the eluent gave the product as an off-white solid (1.07 g, 37% yield). 1H 
NMR (500 MHz, CDCl3) δ 10.66 (d, J = 0.8 Hz, 1H), 7.84 (dd, J1 = 7.7 Hz, J2 = 1.8 Hz, 1H), 
7.46–7.42 (m, 4H), 7.41–7.34 (m, 4H), 7.32–7.27 (m, 1H), 6.33 (s, 1H); 13C NMR (125 MHz, 
CDCl3) δ 189.97, 160.53, 140.59, 135.88, 128.96, 128.56, 128.25, 126.78, 125.73, 121.26, 
114.87, 82.68; HRMS (EI+) m/z Calcd for C20H16O2 [M]+ 288.1150, found 288.1143. 
 
 
N-tert-butyl-1-(2-fluorophenyl)methanimine (3a):1 To a 25-mL round-bottom flask 
equipped with a Teflon-coated magnetic stir bar were added tert-butylamine (0.10 
mL, 1.00 mmol), 5a (288 mg, 1.00 mmol), and toluene (10 mL). The flask was 
equipped with a Dean–Stark apparatus wrapped in aluminum foil and a reflux 
condenser. The reaction was allowed to stir at vigorous reflux (140–150 °C) for 8 h. 
During the course of the reaction, water accumulated at the bottom of the Dean–Stark 
apparatus. The reaction was allowed to cool to room temperature. A small aliquot was taken, 
concentrated in vacuo, and analyzed by 1H NMR to monitor reaction progress. (5a has a 
characteristic 1H NMR peak at 10.66 ppm (d, J = 0.8 Hz, 1H) in CDCl3, and the product (3a) has 
a 1H NMR peak at 8.84 ppm (s, 1H); comparison of these two peaks provides a convenient 
means of monitoring reaction progress.) The reaction had proceeded to only 60% conversion, so 
an additional portion of tert-butylamine (0.16 mL, 1.50 mmol) was added, and the reaction was 
heated for a further 24 h. Upon completion, the reaction mixture was allowed to cool to room 
temperature, and the solvent was removed in vacuo. The crude imine product (3a) was obtained 
as a yellow oil and was used in the subsequent step without further purification. 1H NMR (300 
MHz, CDCl3) δ 8.84 (s, 1H), 7.93 (dd, J1 = 7.7 Hz, J2 = 1.8 Hz, 1H), 7.46–7.40 (m, 4H), 7.38–
7.24 (m, 6H), 7.20 (ddd, J1 = 8.2 Hz, J2 = 7.5 Hz, J3 = 1.8 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H), 6.85 
(d, J = 8.6 Hz, 1H), 6.22 (s, 1H), 1.28 (s, 9H). 
 
 
N-(tert-butyl)-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4a): To a 10-mL 
Schlenk tube equipped with a Teflon-coated magnetic stir bar under Ar, were added 
dry NaOt-Bu (19 mg, 0.20 mmol) and a solution of 3a (assumed to be 1.00 mmol) 
in DMSO (6 mL). The reaction mixture was heated to 100 °C for 1 h. The flask was 
allowed to cool to room temperature, and the reaction was carefully quenched with 
H2O and extracted with Et2O (3 × 50 mL). The organic layers were combined, washed with water 
(50 mL) and brine (50 mL), dried over Na2SO4, filtered, and concentrated in vacuo. Purification 
by silica gel column chromatography using 200:1 hexane:Et2O as the eluent gave the product as 
a viscous yellow oil (87 mg, 25% yield). Analytical data were consistent with that of the sample 
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Scheme S3: SNAr/5-exo-trig cyclization reaction monitored by 1H NMR spectroscopy over time. 
 
General Procedure for 1H NMR Kinetics of Tandem SNAr/5-exo-trig Cyclization: N-tert-
Butyl-1-(2-fluorophenyl)methanimine (1a) (10.0 mmol) was prepared according to the general 
imine condensation procedure. To a 100-mL Schlenk flask equipped with a Teflon-coated 
magnetic stir bar under Ar, were added dry NaH (252 mg, 10.5 mmol), DMSO (20 mL), and 
diphenylmethanol (1.93 g, 10.5 mmol). Upon addition of the alcohol, vigorous bubbling was 
observed. The solution was allowed to stir at room temperature for 1 h, during which time the 
reaction mixture became homogenous. A solution of crude 1a in DMSO (10 mL) was added, and 
the reaction mixture was allowed to stir at room temperature for 36 h, during which time a color 
change to yellow then red/brown was observed. At predetermined intervals, a small aliquot 
(approximately 0.5 mL) was removed and quenched with H2O. The resulting mixture was 
extracted with Et2O, the solvent was removed in vacuo, and a 1H NMR spectrum was collected. 
Reaction progress was monitored by comparing the integrals of diagnostic peaks for 1a, 3a, and 
4a at 8.57 (s, 1H), 8.84 (s, 1H), and 4.90 (s, 1H), respectively. The results are shown in Figure 1 
and Table S1.  
 
Table S1: Reaction progress over time for the transformation depicted in Scheme S3. 
 
	  
%	  (1H	  NMR)	  
time	   1a	   3a	   4a	  
10	  min	   90	   10	   0	  
1	  h	   78	   15	   7	  
2	  h	   62	   19	   20	  
3	  h	   51	   19	   30	  
4	  h	   41	   19	   40	  
12	  h	   16	   14	   70	  
24	  h	   6	   8	   86	  
36	  h	   6	   8	   86	  
 
Characterization of New Compounds: 
 
3-(tert-butyl)-2,2-diphenyl-3,4-dihydro-2H-benzo[e][1,3]oxazine (4a): The title 
compound was prepared from 2-fluorobenzaldehyde (1.05 mL, 10.0 mmol), tert-
butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 mmol) 
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chromatography using 20:1 hexane:Et2O as the eluent gave the product as a viscous yellow oil 
(1.37 g, 40% yield). 1H NMR (500 MHz, CDCl3) δ 7.70–7.63 (m, 2H), 7.43–7.38 (m, 2H), 7.32 
(t, J = 7.6 Hz, 2H), 7.28–7.19 (m, 5H), 7.14 (t, J = 7.7 Hz, 1H), 6.94 (d, J = 8.1 Hz, 1H), 6.88–
6.83 (m, 1H), 4.90 (s, 1H), 0.92 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 158.43, 143.81, 140.31, 
132.51, 129.16, 129.05, 128.17, 127.68, 127.41, 127.37, 127.01, 125.33, 121.34, 110.62, 95.96, 




The title compound was prepared from 2-fluoro-5-nitrobenzaldehyde (1.69 g, 
10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol 
(1.93 g, 10.5 mmol) according to the general procedure. An additional portion 
of NaH (48 mg, 2.0 mmol) was added because the cyclization had not 
proceeded to completion. After the first chromatographic purification on silica gel (20:1 
hexane:Et2O), the product still contained diphenylmethanol. A second purification by silica gel 
column chromatography (10:1 hexane:DCM → 1:1 hexane:DCM) provided the product as a 
white solid (660 mg, 17% yield). 1H NMR (500 MHz, CDCl3) δ 8.23–8.12 (m, 2H), 7.42–7.21 
(m, 11H), 6.09 (s, 1H), 1.84 (s, 1H), 1.28 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 152.03, 
148.38, 145.26, 143.87, 143.58, 128.37, 128.28, 127.78, 127.77, 127.38, 127.37, 124.57, 124.06, 
119.51, 89.97, 89.33, 51.12, 31.10; HRMS (FAB+) m/z Calcd for C24H25N2O3 [M+H]+ 




amine (4c): The title compound was prepared from 2-fluoro-5-
(trifluoromethyl)benzaldehyde (1.41 mL, 10.0 mmol), tert-butylamine (1.04 
mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 mmol) according to the 
general procedure. Purification by silica gel column chromatography using a 
gradient solvent system (40:1 hexane:Et2O → 20:1 hexane:Et2O) as the eluent gave the product 
as an off-white solid (3.13 g, 76% yield). 1H NMR (500 MHz, CDCl3) δ 7.70–7.62 (m, 2H), 7.48 
(s, 1H), 7.43 (dd, J1 = 8.6 Hz, J2 = 1.9 Hz, 1H), 7.40–7.32 (m, 4H), 7.32–7.22 (m, 4H), 6.99 (d, J 
= 8.4 Hz, 1H), 4.98 (s, 1H), 0.95 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 161.04, 143.17, 
139.70, 133.51, 128.97, 128.38, 128.10, 127.77, 127.37, 127.32, 126.98 (q, JC–F = 3.8 Hz), 
124.69 (q, JC–F = 270.0 Hz), 123.88 (q, JC–F = 32.5 Hz), 122.97 (q, JC–F = 3.8 Hz), 110.71, 97.34, 
63.07, 51.24, 30.57; 19F NMR (282 MHz, CDCl3) δ –60.96 (s, 3F); HRMS (FAB+) m/z Calcd 




The title compound was prepared from 2-fluoro-5-methylbenzaldehyde 
(1.22 mL, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and 
diphenylmethanol (1.93 g, 10.5 mmol) according to the general procedure. An 
additional portion of NaH (96 mg, 4.0 mmol) was added because the cyclization had not 
proceeded to completion. Purification by silica gel column chromatography using 40:1 
hexane:Et2O as the eluent gave the product as a colorless oil (2.42 g, 68% yield). 1H NMR (500 
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4H), 7.01 (s, 1H), 6.93 (d, J = 8.1 Hz, 1H), 6.83 (d, J = 8.1 Hz, 1H), 4.85 (s, 1H), 2.23 (s, 3H), 
0.91 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 156.36, 143.89, 140.38, 132.42, 130.52, 129.52, 
129.20, 128.13, 127.62, 127.40, 127.32, 126.97, 125.73, 110.14, 95.95, 63.66, 51.00, 30.44, 




(4e): The title compound was prepared from 2-fluoro-5-methoxybenzaldehyde 
(1.00 mL, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and 
diphenylmethanol (1.93 g, 10.5 mmol) according to the general procedure. An 
additional portion of NaH (192 mg, 8.0 mmol) was added because the cyclization had not 
proceeded to completion. Purification by silica gel column chromatography using a gradient 
solvent system (66:33:1 hexane:DCM:methanol → 80:20:1 hexane:DCM:methanol) as the eluent 
gave the product as a brown oil (821 mg, 22% yield). 1H NMR (500 MHz, CDCl3) δ 7.68–7.64 
(m, 2H), 7.43–7.39 (m, 2H), 7.36–7.32 (m, 2H), 7.29–7.21 (m, 6H), 6.85 (d, J = 8.6 Hz, 1H), 
6.80 (d, J = 2.7 Hz, 1H), 6.70 (dd, J1 = 8.6 Hz, J2 =2.7 Hz, 1H), 4.85 (s, 1H), 3.73 (s, 3H), 0.93 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.65, 152.52, 143.91, 140.33, 133.49, 129.13, 128.19, 
127.70, 127.42, 127.41, 127.09, 114.03, 111.45, 110.64, 96.17, 63.92, 56.10, 51.06, 30.47; 
HRMS (FAB+) m/z Calcd for C25H27O2N [M]+ 373.2042, found 373.2036. 
 
 
 N-(tert-butyl)-7-methoxy-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4f): 
The title compound was prepared from 2-fluoro-3-methoxybenzaldehyde (1.54 g, 
10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 
10.5 mmol) according to the general procedure. An additional portion of NaH (72 
mg, 3.0 mmol) was added because the cyclization had not proceeded to completion. 
Purification by silica gel column chromatography using a gradient solvent system (40:1 
hexane:Et2O → 10:1 hexane:Et2O) as the eluent gave the product as a viscous pale-yellow oil 
(2.54 g, 68% yield). 1H NMR (500 MHz, CDCl3) δ 7.72–7.66 (m, 2H), 7.44–7.38 (m, 2H), 7.36–
7.29 (m, 2H), 7.28–7.18 (m, 4H), 6.86 (dd, J1 = 7.3 Hz, J2 = 0.8 Hz, 1H), 6.82 (t, J = 7.7 Hz, 
1H), 6.75 (dd, J1 = 7.9 Hz, J2 = 1.3 Hz, 1H), 4.90 (s, 1H), 3.90 (s, 3H), 0.91 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 146.95, 145.15, 143.72, 139.99, 133.70, 129.30, 128.14, 127.69, 127.41, 
127.34, 126.94, 121.85, 117.31, 112.18, 96.59, 63.78, 56.34, 51.01, 30.40; HRMS (FAB+) m/z 




The title compound was prepared from 4-chloro-2-fluorobenzaldehyde (1.59 g, 
10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 
g, 10.5 mmol) according to the general procedure. An additional portion of NaH 
(120 mg, 5.0 mmol) was added because the cyclization had not proceeded to 
completion. After the first chromatographic purification on silica gel (6:1 hexane:DCM → 4:1 
hexane:DCM), the product still contained unidentifiable impurities. A second purification by 
silica gel column chromatography (20:1 hexane:acetone) provided the product as a yellow solid 
(1.19 g, 31% yield). 1H NMR (500 MHz, CDCl3) δ 7.67–7.57 (m, 2H), 7.39–7.31 (m, 4H), 7.30–
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Hz, 1H), 4.87 (s, 1H), 0.91 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 159.20, 143.28, 139.81, 
134.32, 131.40, 128.96, 128.28, 127.93, 127.61, 127.30, 127.18, 126.02, 121.59, 111.34, 97.14, 
62.83, 51.12, 30.46; HRMS (FAB+) m/z Calcd for C24H24ClNO [M]+ 377.1546, found 377.1549.  
 
 
 N-(tert-butyl)-4-chloro-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4h): The 
title compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 
mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 
mmol) according to the general procedure. Purification by silica gel column 
chromatography using a gradient solvent system (40:1 hexane:Et2O → 20:1 
hexane:Et2O) as the eluent gave the product as an off-white solid (3.35 g, 89% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.66–7.61 (m, 2H), 7.39–7.32 (m, 4H), 7.32–7.24 (m, 4H), 7.08 (t, J = 8.0 
Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.81 (dd, J1 = 8.0 Hz, J2 = 0.9 Hz, 1H), 4.92 (s, 1H), 0.78 (s, 
9H); 13C NMR (125 MHz, CDCl3) δ 159.80, 142.77, 140.14, 130.62, 130.29, 130.29, 130.15, 
128.32, 127.92, 127.52, 127.00, 122.16, 109.27, 96.45, 63.50, 51.09, 30.32; HRMS (FAB+) m/z 
Calcd for C24H24ClNO [M]+ 377.1546, found 377.1549; X-ray (single-crystal) Crystals suitable 
for X-ray diffraction were grown by vapor diffusion of hexane into a saturated solution of the 
title compound in Et2O at room temperature (CCDC 1058167).3 
 
 
4-chloro-N-isobutyl-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4i): The 
title compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 
mmol), isobutylamine (0.73 g, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 
mmol) according to the general procedure. An additional portion of NaH (48 mg, 
2.0 mmol) was added because the cyclization had not proceeded to completion. 
Purification by silica gel column chromatography using 200:1 hexane:Et2O as the 
eluent gave the product as a yellow oil (2.60 g, 69% yield). 1H NMR (500 MHz, CDCl3) δ 7.60 
(d, J = 7.7 Hz, 2H), 7.52 (d, J = 7.6 Hz, 2H), 7.31 (q, J = 6.8 Hz, 4H), 7.24 (q, J = 7.4 Hz, 2H), 
7.13 (t, J = 8.0 Hz, 1H), 6.87 (t, J = 7.2 Hz, 2H), 4.97 (s, 1H), 2.13 (dd, J1 = 10.7 Hz, J2 = 6.3 
Hz, 1H), 1.82 (dd, J1 = 10.3 Hz, J2 = 6.8 Hz, 1H), 1.40 (s, 1H), 1.34–1.23 (m, 1H), 0.58 (d, J = 
6.6 Hz, 3H), 0.55 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, (CD3)2CO) δ 160.49, 145.40, 
141.45, 132.22, 131.72, 129.23, 128.83, 128.54, 128.49, 128.13, 128.06, 127.31, 122.38, 109.97, 
96.36, 68.44, 54.51, 29.62, 20.76, 20.73; HRMS (FAB+) m/z Calcd for C24H24ClNO [M]+ 
377.1546, found 377.1540. 
 
 
4-chloro-N-isopropyl-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4j): The 
title compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 
mmol), isopropylamine (0.85 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 
mmol) according to the general procedure. Purification by silica gel column 
chromatography using a gradient solvent system (200:1 hexane:Et2O → 40:1 
hexane:Et2O) as the eluent gave the product as an off-white solid (2.57 g, 71% 
yield). 1H NMR (500 MHz, CD2Cl2) δ 7.86–7.81 (m, 2H), 7.67–7.63 (m, 2H), 7.55–7.38 (m, 
6H), 7.25 (t, J = 8.0 Hz, 1H), 7.07–6.99 (m, 2H), 5.16 (s, 1H), 2.55 (sept, J = 6.2 Hz, 1H), 1.42 
(s, 1H), 1.18 (d, J = 6.1 Hz, 3H), 0.67 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CD2Cl2) δ 
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122.34, 109.64, 96.61, 65.93, 47.44, 23.74, 22.93; HRMS (FAB+) m/z Calcd for C23H22ClNO 
[M]+ 363.1390, found 363.1405. 
 
 
4-chloro-N-cyclohexyl-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4k): The 
title compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 
mmol), cyclohexylamine (1.12 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 
10.5 mmol) according to the general procedure. Purification by silica gel column 
chromatography using 40:1 hexane:Et2O as the eluent gave the product as an off-
white solid (2.59 g, 64% yield). 1H NMR (500 MHz, CDCl3) δ 7.63–7.59 (m, 2H), 
7.48–7.42 (m, 2H), 7.36–7.32 (m, 2H), 7.31–7.23 (m, 4H), 7.07 (t, J = 8.0 Hz, 1H), 6.87–6.79 
(m, 2H), 4.99 (s, 1H), 2.03–1.90 (m, 2H), 1.72–1.60 (m, 1H), 1.49–1.37 (m, 2H), 1.21 (bs, 1H), 
1.16–1.05 (m, 1H), 1.06–0.94 (m, 2H), 0.90–0.79 (m, 1H), 0.79–0.72 (m, 1H), 0.70–0.60 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 159.28, 143.17, 139.87, 131.33, 130.47, 128.63, 128.36, 
127.95, 127.91, 127.75, 127.67, 127.18, 121.90, 109.08, 96.12, 64.95, 55.11, 33.75, 33.22, 26.11, 




furan-3-amine (4l): The title compound was prepared from 2-chloro-6-
fluorobenzaldehyde (1.59 g, 10.0 mmol), tert-octylamine (1.60 mL, 
10.0 mmol), and diphenylmethanol (1.93 g, 10.5 mmol) according to the 
general procedure. Purification by silica gel column chromatography using a 
gradient solvent system (200:1 hexane:Et2O → 40:1 hexane:Et2O) as the eluent 
gave the product as an off-white solid (2.77 g, 64% yield). 1H NMR (500 MHz, CDCl3) δ 7.65–
7.59 (m, 2H), 7.39–7.32 (m, 4H), 7.30–7.26 (m, 4H), 7.08 (t, J = 8.0 Hz, 1H), 6.84 (d, J = 8.0 
Hz, 1H), 6.81 (dd, J1 = 8.0 Hz, J2 = 0.7 Hz, 1H), 4.97 (s, 1H), 1.22–1.07 (m, 5H), 0.85 (s, 9H), 
0.53 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 159.69, 142.76, 140.28, 130.39, 130.37, 130.21, 
130.09, 128.31, 127.86, 127.83, 127.42, 127.06, 122.16, 109.28, 96.52, 63.03, 56.85, 55.16, 





amine (4m): The title compound was prepared from 2-chloro-6-
fluorobenzaldehyde (1.59 g, 10.0 mmol), 1-adamantylamine (1.51 g, 10.0 
mmol), and diphenylmethanol (1.93 g, 10.5 mmol) according to the general 
procedure. An additional portion of NaH (72 mg, 3.0 mmol) was added because 
the cyclization had not proceeded to completion. Purification by silica gel 
column chromatography using a gradient solvent system (200:1 hexane:Et2O → 40:1 
hexane:Et2O) as the eluent gave the product as a white solid (3.54 g, 78% yield). 1H NMR (500 
MHz, CDCl3) δ 7.65–7.62 (m, 2H), 7.39–7.32 (m, 4H), 7.31–7.23 (m, 4H), 7.07 (t, J = 8.0 Hz, 
1H), 6.84 (d, J = 7.9 Hz, 1H), 6.81 (dd, J1 = 8.0 Hz, J2 = 0.8 Hz, 1H), 5.04 (s, 1H), 1.88 (s, 3H), 
1.52 (d, J = 12.3 Hz, 3H), 1.42 (d, J = 11.3 Hz, 3H), 1.37–1.29 (m, 3H), 1.15 (dq, J1 = 11.9 Hz, 
J2 = 2.8 Hz, 3H), 0.95 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 159.75, 142.71, 140.05, 130.52, 
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4-chloro-2,2-diphenyl-N-trityl-2,3-dihydrobenzofuran-3-amine (4n): The title 
compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 mmol), 
triphenylmethylamine (2.59 g, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 
mmol) according to the general procedure. An additional portion of NaH (72 mg, 
3.0 mmol) was added because the cyclization had not proceeded to completion. 
Purification by silica gel column chromatography using a gradient solvent system 
(100:1 hexane:Et2O → 40:1 hexane:Et2O) as the eluent gave the product as a white solid (1.58 g, 
28% yield). 1H NMR (500 MHz, CDCl3) δ 7.35–6.98 (m, 28H), 6.87 (d, J = 7.9 Hz, 1H), 6.57 
(dd, J1 = 8.0 Hz, J2 = 0.8 Hz, 1H), 4.92 (d, J = 6.5 Hz, 1H), 2.35 (d, J = 6.5 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 159.31, 146.11, 143.26, 140.33, 131.99, 131.89, 130.04, 129.54, 128.20, 
128.19, 127.59, 127.55, 127.52, 127.38, 126.60, 126.30, 121.52, 109.53, 98.52, 71.40, 59.99; 
HRMS (FAB+) m/z Calcd for C39H30ClNO [M]+ 563.2016, found 563.2032; X-ray (single-
crystal) Colorless block crystals suitable for X-ray diffraction were grown from a solution of the 
title compound in 40:1 hexane:Et2O at room temperature (CCDC 1058169).3 
 
 
4-chloro-N,2,2-triphenyl-2,3-dihydrobenzofuran-3-amine (4o): The title 
compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 10.0 mmol), 
aniline (0.91 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 mmol) 
according to the general procedure. An additional portion of NaH (96 mg, 4.0 
mmol) was added because the cyclization had not proceeded to completion. 
Purification by silica gel column chromatography using 40:1 hexane:Et2O as the 
eluent gave the product as a yellow oil (889 mg, 22% yield). 1H NMR (500 MHz, CDCl3) δ 
7.68–7.58 (m, 2H), 7.39–7.26 (m, 5H), 7.21–7.15 (m, 4H), 7.11–7.04 (m, 2H), 6.93 (d, J = 8.0 
Hz, 1H), 6.90 (dd, J1 = 8.0 Hz, J2 = 0.7 Hz, 1H), 6.67 (tt, J1 = 7.4 Hz, J2 = 1.0 Hz, 1H), 6.51–
6.47 (m, 2H), 5.86 (d, J = 10.4 Hz, 1H), 3.54 (d, J = 10.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 159.51, 146.75, 143.19, 139.37, 132.08, 131.13, 129.19, 128.63, 128.17, 127.88, 127.82, 
127.29, 126.76, 126.73, 122.17, 118.19, 113.73, 109.13, 96.08, 64.48; HRMS (FAB+) m/z Calcd 
for C26H20ClNO [M]+ 397.1233, found 397.1237. 
 
 
 N-(tert-butyl)-4-chloro-2,2-di-p-tolyl-2,3-dihydrobenzofuran-3-amine (4p): 
The title compound was prepared from 2-chloro-6-fluorobenzaldehyde (1.59 g, 
10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and 4,4’-dimethylbenzhydrol 
(2.23 g, 10.5 mmol) according to the general procedure. An additional portion of 
NaH (120 mg, 5.0 mmol) was added because the cyclization had not proceeded to 
completion. Purification by silica gel column chromatography using a gradient 
solvent system (100:1 hexane:Et2O → 40:1 hexane:Et2O) as the eluent gave the 
product as an off-white solid (2.69 g, 66% yield). 1H NMR (500 MHz, CDCl3) δ 7.53–7.48 (m, 
2H), 7.25–7.20 (m, 2H), 7.17 (d, J = 8.0 Hz, 2H), 7.10–7.05 (m, 3H), 6.83 (d, J = 7.9 Hz, 1H), 
6.81 (dd, J1 = 8.0 Hz, J2 = 0.8 Hz, 1H), 4.89 (s, 1H), 2.33 (s, 6H), 0.80 (s, 9H); 13C NMR (125 
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127.70, 127.34, 122.00, 109.19, 96.32, 63.22, 51.09, 30.31, 21.24, 21.19; HRMS (FAB+) m/z 




amine (4q): The title compound was prepared from 2-chloro-6-
fluorobenzaldehyde (1.59 g, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), 
and 4,4’-dimethoxybenzhydrol (2.57 g, 10.5 mmol) according to the general 
procedure. An additional portion of NaH (120 mg, 5.0 mmol) was added 
because the cyclization had not proceeded to completion. Purification by silica 
gel column chromatography using 10:1 hexane:Et2O as the eluent gave the 
product as an off-white solid (2.50 g, 57% yield). 1H NMR (500 MHz, CDCl3) δ 
7.55–7.49 (m, 2H), 7.28–7.22 (m, 2H), 7.08 (t, J = 8.0 Hz, 1H), 6.91–6.86 (m, 2H), 6.82 (d, J = 
4.6 Hz, 1H), 6.81–6.77 (m, 3H), 4.83 (s, 1H), 3.79 (s, 6H), 0.80 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 159.74, 159.35, 159.08, 134.81, 132.70, 130.55, 130.29, 130.23, 128.58, 121.99, 
113.62, 112.25, 109.17, 96.03, 63.07, 55.39, 55.33, 51.18, 30.26; HRMS (FAB+) m/z Calcd for 




amine (4r): The title compound was prepared from 2-chloro-6-
fluorobenzaldehyde (1.59 g, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), 
and 4,4’-difluorobenzhydrol (2.31 g, 10.5 mmol) according to the general 
procedure. An additional portion of NaH (120 mg, 5.0 mmol) was added because 
the cyclization had not proceeded to completion. Purification by silica gel column 
chromatography using a gradient solvent system (100:1 hexane:Et2O → 40:1 
hexane:Et2O) as the eluent gave the product as a white solid (1.97 g, 48% yield). 
1H NMR (500 MHz, CDCl3) δ 7.63–7.53 (m, 2H), 7.33–7.26 (m, 2H), 7.11 (t, J = 8.0 Hz, 1H), 
7.09–7.03 (m, 2H), 6.99–6.93 (m, 2H), 6.87–6.80 (m, 2H), 4.81 (s, 1H), 0.79 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 163.55 (d, JC–F = 38.5 Hz), 161.58 (d, JC–F = 38.6 Hz), 159.50, 138.11 (d, 
JC–F = 3.1 Hz), 135.72 (d, JC–F = 3.0 Hz), 132.10 (d, JC–F = 8.0 Hz), 130.56, 130.54, 129.71, 
129.13 (d, JC–F = 8.1 Hz), 122.38, 115.38 (d, JC–F = 21.3 Hz), 113.68 (d, JC–F = 21.1 Hz), 109.28, 
95.58, 63.35, 51.17, 30.22; 19F NMR (282 MHz, CDCl3) δ –114.30 (tt, JF–H1 = 8.5 Hz, JF–H2 = 
5.3 Hz, 1F), –114.78 (tt, JF–H1 = 8.6 Hz, JF–H2 = 5.5 Hz, 1F); HRMS (FAB+) m/z Calcd for 




dibenzo[a,d][7]annulen]-3-amine (4s): The title compound was prepared from 2-
chloro-6-fluorobenzaldehyde (1.59 g, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 
mmol), and dibenzosuberol (2.21 g, 10.5 mmol) according to the general 
procedure. Purification by silica gel column chromatography using a gradient 
solvent system (100:1 hexane:Et2O → 40:1 hexane:Et2O) as the eluent gave the 
product as a white solid (2.67 g, 66% yield). 1H NMR (500 MHz, CDCl3) δ 7.90 
(dd, J1 = 7.9 Hz, J2 = 1.5 Hz, 1H), 7.31 (dd, J1 = 8.0 Hz, J2 = 1.2 Hz, 1H), 7.24–7.05 (m, 6H), 
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3.77 (ddd, J1 = 15.0 Hz, J2 = 11.4 Hz, J3 = 3.8 Hz, 1H), 3.39 (ddd, J1 = 16.6 Hz, J2 = 6.7 Hz, J3 = 
3.7 Hz, 1H), 3.03 (ddd, J1 = 16.1 Hz, J2 = 11.4 Hz, J3 = 4.0 Hz, 1H), 2.94 (ddd, J1 = 14.9 Hz, J2 
= 6.7 Hz, J3 = 4.0 Hz, 1H), 0.87 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 159.23, 140.87, 139.75, 
138.20, 136.88, 131.22, 130.87, 130.70, 130.23, 129.91, 129.53, 127.80, 127.68, 126.50, 126.20, 
125.40, 122.20, 109.03, 97.31, 66.19, 50.65, 34.50, 32.83, 30.65; HRMS (FAB+) m/z Calcd for 




The title compound was prepared from 5-chloro-2-fluorobenzaldehyde (1.59 g, 
10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 
g, 10.5 mmol) according to the general procedure. An additional portion of NaH 
(120 mg, 5.0 mmol) was added because the cyclization had not proceeded to 
completion. Purification by silica gel column chromatography using a gradient solvent system 
(100:1 hexane:Et2O → 40:1 hexane:Et2O) as the eluent provided a mixture of 4t and 6t in 1.3:1 
molar ratio, as determined by 1H NMR (2.78 g, 74% yield). Analytically pure samples of both 4t 
and 6t were obtained for the purposes of characterization via PTLC using 100:1 hexane:Et2O as 
the eluent. 1H NMR (500 MHz, CDCl3) δ 7.67–7.61 (m, 2H), 7.41–7.32 (m, 4H), 7.32–7.23 (m, 
4H), 7.17 (d, J = 2.2 Hz, 1H), 7.10 (dd, J1 = 8.5 Hz, J2 = 2.2 Hz, 1H), 6.86 (d, J = 8.5 Hz, 1H), 
4.88 (s, 1H), 1.24 (s, 1H), 0.93 (s, 9H); 13C NMR (100 MHz, (CD3)2CO) δ 158.22, 144.48, 
141.26, 136.06, 129.97, 129.57, 129.08, 128.70, 128.33, 128.22, 127.78, 126.48, 126.02, 112.59, 




2-(1-(tert-butylamino)-2,2-diphenylvinyl)-4-chlorophenol (6t): The title 
compound was prepared using the procedure described above for 4t. 1H NMR 
(500 MHz, CDCl3) δ 9.06 (s, 1H), 7.44–7.37 (m, 2H), 7.35–7.27 (m, 3H), 7.07–
6.98 (m, 4H), 6.90–6.86 (m, 2H), 6.80 (d, J = 2.6 Hz, 1H), 6.77 (d, J = 8.6 Hz, 
1H), 3.55 (s, 1H), 1.04 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 155.54, 140.98, 
140.52, 137.46, 130.85, 130.20, 130.05, 129.28, 129.09, 128.57, 127.89, 127.49, 126.16, 125.82, 




N-(tert-butyl)-7-chloro-2,2-diphenyl-2,3-dihydrobenzofuran-3-amine (4u): The 
title compound was prepared from 3-chloro-2-fluorobenzaldehyde (1.59 g, 10.0 
mmol), tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 
mmol) according to the general procedure. An additional portion of NaH (240 mg, 
10.0 mmol) was added because the cyclization had not proceeded to completion. 
Purification by silica gel column chromatography using a gradient solvent system (40:1 
hexane:Et2O → 20:1 hexane:Et2O) as the eluent provided a mixture of 4u and 6u in 1.7:1 molar 
ratio, as determined by 1H NMR (2.80 g, 74% yield). Analytically pure samples of both 4u and 
6u were obtained for the purposes of characterization via PTLC using 100:1 hexane:Et2O as the 
eluent. 1H NMR (500 MHz, CDCl3) δ 7.72–7.67 (m, 2H), 7.45–7.41 (m, 2H), 7.38–7.33 (m, 
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Hz, 1H), 6.80 (t, J = 7.7 Hz, 1H), 4.94 (s, 1H), 0.93 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
154.51, 143.20, 139.45, 134.41, 129.18, 129.06, 128.33, 127.94, 127.64, 127.24, 127.20, 123.62, 
122.29, 116.16, 96.94, 64.29, 51.17, 30.46; HRMS (FAB+) m/z Calcd for C24H24ClNO [M]+ 
377.1546, found 377.1531.  
 
 
2-(1-(tert-butylamino)-2,2-diphenylvinyl)-6-chlorophenol (6u): The title 
compound was prepared using the procedure described above for 4u. 1H NMR 
(500 MHz, CDCl3) δ 9.79 (s, 1H), 7.43–7.38 (m, 2H), 7.36–7.28 (m, 3H), 7.17 (dd, 
J1 = 8.0 Hz, J2 = 1.6 Hz, 1H), 7.05–6.96 (m, 3H), 6.91–6.85 (m, 3H), 6.73 (dd, J1 = 
7.6 Hz, J2 = 1.6 Hz, 1H), 6.47 (t, J = 7.8 Hz, 1H), 3.58 (s, 1H), 1.59 (s, 1H), 1.03 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 152.75, 141.16, 140.50, 137.72, 130.29, 130.06, 129.85, 
129.76, 129.12, 128.94, 127.84, 127.53, 125.99, 125.83, 120.61, 119.83, 54.04, 30.01; HRMS 
(FAB+) m/z Calcd for C24H24ClNO [M]+ 377.1546, found 377.1559; X-ray (single-crystal) 
Colorless block crystals suitable for X-ray diffraction were grown from a solution of the title 




The title compound was prepared from 5-bromo-2-fluorobenzaldehyde 
(1.18 mL, 10.0 mmol), tert-butylamine (1.04 mL, 10.0 mmol), and 
diphenylmethanol (1.93 g, 10.5 mmol) according to the general procedure. An 
additional portion of NaH (192 mg, 8.0 mmol) was added because the cyclization had not 
proceeded to completion. Purification by silica gel column chromatography using 40:1 
hexane:Et2O as the eluent provided a mixture of 4v and 6v in 6.3:1 molar ratio, as determined by 
1H NMR (3.67 g, 87% yield). Analytically pure samples of both 4v and 6v were obtained for the 
purposes of characterization via PTLC using 100:1 hexane:Et2O as the eluent. 1H NMR (500 
MHz, CDCl3) δ 7.67–7.64 (m, 2H), 7.42–7.25 (m, 10H), 6.85 (d, J = 8.5 Hz, 1H), 4.91 (s, 1H), 
0.95 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 157.52, 143.22, 139.70, 135.05, 131.87, 129.00, 
128.37, 128.30, 127.96, 127.66, 127.33, 127.22, 113.00, 112.36, 96.75, 63.34, 51.18, 30.47; 
HRMS (FAB+) m/z Calcd for C24H2481BrNO [M]+ 423.1021, found 423.1033. 
 
 
4-bromo-2-(1-(tert-butylamino)-2,2-diphenylvinyl)phenol (6v): The title 
compound was prepared using the procedure described above for 4v. 1H NMR 
(500 MHz, CDCl3) δ 9.10 (s, 1H), 7.40 (t, J = 7.5 Hz, 2H), 7.35–7.28 (m, 3H), 
7.17 (dd, J1 = 8.6 Hz, J2 = 2.5 Hz, 1H), 7.10–6.99 (m, 3H), 6.93 (d, J = 2.5 Hz, 
1H), 6.90–6.86 (m, 2H), 6.72 (d, J = 8.6 Hz, 1H), 3.54 (s, 1H), 1.04 (s, 9H); 13C 
NMR (125 MHz, CDCl3) δ 156.04, 140.96, 140.49, 137.36, 133.77, 132.17, 130.21, 130.04, 
129.10, 128.71, 127.90, 127.50, 126.36, 126.19, 117.45, 111.18, 53.95, 30.14; HRMS (FAB+) 
m/z Calcd for C24H2481BrNO [M]+ 423.1021, found 423.1019. 
 
 
N-(tert-butyl)-2,2-diphenyl-2,3-dihydrofuro[2,3-b]pyridin-3-amine (4w): The 
title compound was prepared from 2-fluoro-3-formylpyridine (1.25 g, 10.0 mmol), 
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according to the general procedure. Purification by silica gel column chromatography using a 
gradient solvent system (80:20:1 DCM:hexane:methanol → 25:1 DCM:methanol) as the eluent 
provided 4w as a brown oil (497 mg, 14% yield) and 6w as a brown solid (113 mg, 3% yield). 
1H NMR (500 MHz, CDCl3) δ 8.08 (dd, J1 = 5.1 Hz, J2 = 1.4 Hz, 1H), 7.74–7.70 (m, 2H), 7.53 
(ddd, J1 = 7.2 Hz, J2 = 1.7 Hz, J3 = 0.8 Hz, 1H), 7.46–7.42 (m, 2H), 7.37–7.32 (m, 2H), 7.31–
7.22 (m, 4H), 6.81 (dd, J1 = 7.2, J2 = 5.1 Hz, 1H), 4.98 (s, 1H), 0.98 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 166.73, 147.98, 143.25, 139.48, 134.45, 128.53, 128.31, 127.97, 127.63, 127.37, 
127.23, 125.56, 117.60, 94.69, 62.06, 51.22, 30.59; HRMS (FAB+) m/z Calcd for C23H24N2O 
[M]+ 344.1889, found 344.1878. 
 
 
3-(1-(tert-butylamino)-2,2-diphenylvinyl)pyridin-2-ol (6w): The title compound 
was prepared using the procedure described above for 4w. 1H NMR (500 MHz, 
CDCl3) δ 13.06 (s, 1H), 7.44–7.31 (m, 6H), 7.22 (tt, J1 = 7.1 Hz, J2 = 2.0 Hz, 1H), 
7.05–6.97 (m, 4H), 6.95–6.89 (m, 1H), 6.09 (t, J = 6.6 Hz, 1H), 3.85 (s, 1H), 1.11 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 164.78, 143.94, 143.30, 141.96, 139.90, 
134.99, 130.94, 130.90, 130.21, 128.70, 127.63, 126.51, 125.15, 121.89, 106.47, 52.52, 30.81; 
HRMS (FAB+) m/z Calcd for C23H25N2O [M+H]+ 345.1967, found 345.1959. 
 
 
N-(tert-butyl)-2,2-diphenyl-2,3-dihydrofuro[3,2-b]pyridin-3-amine (4x): The 
title compound was prepared from 3-fluoro-2-formylpyridine (1.25 g, 10.0 mmol), 
tert-butylamine (1.04 mL, 10.0 mmol), and diphenylmethanol (1.93 g, 10.5 mmol) 
according to the general procedure. An additional portion of NaH (126 mg, 4.0 
mmol) was added because the cyclization had not proceeded to completion. After 
the first chromatographic purification on silica gel (2:1 hexane:Et2O), the product still contained 
unidentifiable impurities. A second purification by silica gel column chromatography (80:20:1 
DCM:hexane:methanol → 80:10:1 DCM:hexane:methanol) provided 4x as a brown oil (804 mg, 
23% yield) and 6x as a white solid (1.11 g, 32%). 1H NMR (500 MHz, CDCl3) δ 8.10 (d, J = 4.7 
Hz, 1H), 7.66 (d, J = 7.7 Hz, 2H), 7.42 (d, J = 7.5 Hz, 2H), 7.37–7.21 (m, 6H), 7.15 (d, J = 8.1 
Hz, 1H), 7.07–6.98 (m, 1H), 4.99 (s, 1H), 1.01 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.43, 
152.18, 143.25, 142.76, 139.72, 128.87, 128.28, 127.99, 127.66, 127.35, 127.29, 123.32, 116.98, 




2-(1-(tert-butylamino)-2,2-diphenylvinyl)pyridin-3-ol (6x): The title compound 
was prepared using the procedure described above for 4x. The NMR spectra for 6x 
suggest that two rotamers may be present in solution; only peaks corresponding to 
the major rotamer are reported. 1H NMR (400 MHz, CDCl3) δ 9.08 (s, 1H), 7.89–
7.80 (m, 1H), 7.40 (d, J = 6.5 Hz, 3H), 7.35–7.28 (m, 1H), 7.27–7.21 (m, 1H), 
7.14–7.09 (m, 1H), 7.06–6.93 (m, 4H), 6.85–6.78 (m, 2H), 3.64 (s, 1H), 1.05 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 153.54, 144.15, 141.05, 140.85, 140.50, 137.69, 130.16, 129.97, 129.50, 
129.02, 127.72, 127.50, 125.74, 124.15, 122.34, 54.24, 30.21; HRMS (FAB+) m/z Calcd for 
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X-RAY CRYSTALLOGRAPHY METHODS AND RESULTS 
 
Refinement Details: In each case, crystals were mounted on a glass fiber or nylon loop using 
Paratone oil, then placed on the diffractometer under a nitrogen stream. Low-temperature (100 
K) X-ray data were obtained on a Bruker Kappa diffractometer coupled to a Apex II CCD 
detector with graphite monochromated Mo Kα radiation (λ = 0.71073 Å) for the structures of 
compounds 4h (CCDC 1058167) and 4n (CCDC 1058169) and on a Bruker AXS D8 VENTURE 
KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Mo Kα radiation (λ = 
0.71073 Å) from an IµS micro-source for the structure of compound 6u (CCDC 1058168). All 
diffractometer manipulations, including data collection, integration, and scaling were carried out 
using the Bruker APEXII software.4 Absorption corrections were applied using SADABS.5 
Space groups were determined on the basis of systematic absences and intensity statistics and the 
structures were solved by direct methods using XS6 or by intrinsic phasing using XT 
(incorporated into SHELXTL) and refined by full-matrix least squares on F2. All non-hydrogen 
and hydride atoms were refined using anisotropic displacement parameters. Non-hydride 
hydrogen atoms were placed in the idealized positions and refined using a riding model. The 
structure was refined (weighed least squares refinement on F2) to convergence. Graphical 
representation of structures with 50% probability thermal ellipsoids was generated using 
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 Table S2: Crystal data and structure refinement for 4h (CCDC 1058167). 
 
Identification code  a14314 
Empirical formula  C24 H24 Cl N O 
Formula weight  377.89 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions a = 16.3879(9) Å α = 90° 
 b = 7.0026(4) Å β = 103.718(3)° 
 c = 17.8667(10) Å g = 90° 
Volume 1991.86(19) Å3 
Z 4 
Density (calculated) 1.260 g/cm3 
Absorption coefficient 0.205 mm–1 
F(000) 800 
Crystal size 0.41 × 0.39 × 0.34 mm3 
Theta range for data collection 2.392 to 48.941°. 
Index ranges -34 ≤ h ≤ 34, -14 ≤ k ≤ 14, -34 ≤ l ≤ 37 
Reflections collected 152651 
Independent reflections 19792 [R(int) = 0.0448] 
Completeness to theta = 25.000° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9478 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 19792 / 0 / 340 
Goodness-of-fit on F2 1.703 
Final R indices [I>2σ(I)] R1 = 0.0440, wR2 = 0.1046 
R indices (all data) R1 = 0.0713, wR2 = 0.1102 
Extinction coefficient n/a 
Largest diff. peak and hole 0.609 and -0.689 e·Å–3 
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Figure S1. X-ray crystal structure of 4h with 50% probability ellipsoids. Hydrogen atoms omitted 
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 Table S3: Crystal data and structure refinement for 4n (CCDC 1058169). 
 
Identification code  P14056 
Empirical formula  C39 H30 Cl N O 
Formula weight  564.09 
Temperature  160(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 14.7817(5) Å α = 90° 
 b = 10.4931(3) Å β = 110.0396(11)° 
 c = 20.1054(7) Å γ = 90° 
Volume 2929.66(17) Å3 
Z 4 
Density (calculated) 1.279 g/cm3 
Absorption coefficient 0.163 mm–1 
F(000) 1184 
Crystal size 0.200 × 0.200 × 0.200 mm3 
Theta range for data collection 2.449 to 30.503°. 
Index ranges -21 ≤ h ≤ 21, -14 ≤ k ≤14, -28 ≤ l ≤ 28 
Reflections collected 118977 
Independent reflections 8923 [R(int) = 0.0530] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7471 and 0.7196 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8923 / 1 / 382 
Goodness-of-fit on F2 1.079 
Final R indices [I>2σ(I)] R1 = 0.0530, wR2 = 0.1360 
R indices (all data) R1 = 0.0729, wR2 = 0.1495 
Extinction coefficient n/a 
Largest diff. peak and hole 0.694 and -0.577 e.Å–3 
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Figure S2. X-ray crystal structure of 4n with 50% probability ellipsoids. Hydrogen atoms omitted 
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 Table S4: Crystal data and structure refinement for 6u (CCDC 1058168). 
 
Identification code  a14340 
Empirical formula  C24 H24 Cl N O 
Formula weight  377.89 
Temperature  100.0 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 1 21/n 1 
Unit cell dimensions a = 12.0241(5) Å α = 90° 
 b = 10.8634(4) Å β = 92.829(2)° 
 c = 15.0306(6) Å γ = 90° 
Volume 1960.94(13) Å3 
Z 4 
Density (calculated) 1.280 Mg/m3 
Absorption coefficient 0.208 mm–1 
F(000) 800 
Crystal size 0.4 x 0.29 x 0.19 mm3 
Theta range for data collection 2.119 to 41.861°. 
Index ranges -22 ≤ h ≤ 22, -20 ≤ k ≤ 20, -28 ≤ l ≤ 28 
Reflections collected 140172 
Independent reflections 13399 [R(int) = 0.0477] 
Completeness to theta = 25.000° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9335 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13399 / 0 / 340 
Goodness-of-fit on F2 1.047 
Final R indices [I>2σ(I)] R1 = 0.0372, wR2 = 0.1016 
R indices (all data) R1 = 0.0526, wR2 = 0.1120 
Extinction coefficient n/a 
Largest diff. peak and hole 0.797 and -0.217 e.Å–3 
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Figure S3. X-ray crystal structure of 6u with 50% probability ellipsoids. Hydrogen atoms omitted 
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